マイクロニードルドラッグデリバリーシステムの世界市場レポート 2025年

マイクロニードルドラッグデリバリーシステムの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR18.0％で114億4,000万米ドルに成長します。予測期間の成長は、化粧品・美容用途、新興治療、小児・老人用途、世界ヘルス構想、ポイントオブケア検査に起因しています。予測期間の主な動向には、スマートマイクロニードル、材料科学の進歩、ウェアラブル技術の進歩、生分解性材料、連続グルコースモニタリングなどがあります。

研究努力の高まりとワクチン接種の需要がマイクロニードルドラッグデリバリーシステム市場の成長を促進すると予測されています。研究者は、マイクロニードルをワクチン投与の代替方法と見なしており、受領者はほとんど痛みを感じずに済みます。当初はインフルエンザや麻疹ワクチン用に開発されたマイクロニードルパッチは、現在ではCOVID-19ワクチンの投与にも利用されるようになってきています。例えば、2024年4月、英国の政府機関である国家統計局によると、英国政府の研究開発（R&D）に対する純支出は、EU研究開発予算への拠出を除くと、2021年の153億7,000万米ドル（140億ポンド）から2022年には170億1,000万米ドル（155億ポンド）に増加し、10.5%の増加となった。EU研究開発予算への拠出と知識移転活動を含めると、研究開発への純支出は2022年に180億600万米ドル（164億英ポンド）に達し、2021年の164億6,000万米ドル（150億英ポンド）から8.9%増加しました。このように、ワクチン接種プロセスに関する調査と需要の増加が、マイクロニードルドラッグデリバリーシステム市場の前進を後押ししています。

肥満の有病率の上昇は、今後のマイクロニードルドラッグデリバリーシステム市場の成長を促進すると予想されます。肥満とは、個人の健康に悪影響を及ぼす体脂肪の過剰によって定義される病状です。マイクロニードルドラッグデリバリーシステムは、患者に薬を投与するための便利で苦痛のない方法を提供することで、肥満管理に利用されています。例えば、2024年5月、英国の政府機関であるOffice for Health Improvement and Disparitiesは、2022年から2023年にかけて、英国の18歳以上の成人の64.0％が太りすぎか肥満と共存していると推定しました。このうち、26.2％が肥満と同居していると分類されました。太りすぎ（肥満を含む）の有病率は、女性（58.6％）よりも男性（69.2％）の方が高かったです。しかし、成人の肥満率は男女とも同程度であり、男性の26.4％、女性の26.2％が肥満でした。したがって、肥満の有病率の増加がマイクロニードルドラッグデリバリーシステム市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界成長分析と戦略分析フレームワーク

• 世界のマイクロニードルドラッグデリバリーシステムPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のマイクロニードルドラッグデリバリーシステム市場成長率分析
• 世界のマイクロニードルドラッグデリバリーシステム市場の実績：規模と成長, 2019-2024
• 世界のマイクロニードルドラッグデリバリーシステム市場の予測：規模と成長, 2024-2029, 2034F
• 世界のマイクロニードルドラッグデリバリーシステム総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のマイクロニードルドラッグデリバリーシステム市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホロー
• 多孔質
• 固体
• その他のテクノロジー
• 世界のマイクロニードルドラッグデリバリーシステム市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドラッグデリバリー
• ワクチンの配送
• その他の用途
• 世界のマイクロニードルドラッグデリバリーシステム市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断研究所
• ライフサイエンス
• 研究ラボ
• 病院
• 外来手術センター
• その他のエンドユーザー
• 世界のマイクロニードルドラッグデリバリーシステム市場：中空のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 中空マイクロニードル
• コーティングされた中空マイクロニードル
• 世界のマイクロニードルドラッグデリバリーシステム市場：多孔質のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 多孔質シリコンマイクロニードル
• ハイドロゲルベースの多孔質マイクロニードル
• 世界のマイクロニードルドラッグデリバリーシステム市場：固体のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ワクチン接種用固形マイクロニードル
• ドラッグデリバリー用固体マイクロニードル
• 世界のマイクロニードルドラッグデリバリーシステム市場：その他のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 溶解マイクロニードル
• 生分解性マイクロニードル
• マイクロインフュージョンシステム

第7章 地域別・国別分析

• 世界のマイクロニードルドラッグデリバリーシステム市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のマイクロニードルドラッグデリバリーシステム市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• マイクロニードルドラッグデリバリーシステム市場：競合情勢
• マイクロニードルドラッグデリバリーシステム市場：企業プロファイル
  • 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • Zosano Pharma Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Becton-Dickinson Technologies Overview, Products and Services, Strategy and Financial Analysis
  • Nanopass Technologies Overview, Products and Services, Strategy and Financial Analysis
  • Corium Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Valeritas Inc.
• Microdermics
• TheraJect Inc.
• LTS Lohmann Therapie-Systeme AG
• BioSerenTach（BT）
• Sorrento Therapeutics
• Debiotech
• Raphas Co. Ltd.
• QuadMedicine
• Snvia Co. Ltd.
• NanoBiosciences LLC
• AdminMed nanoBioSciences LLC
• Nitto Denko Corporation
• MyLife Technologies
• Innoture Medical Technology Limited

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、セグメント、戦略

• マイクロニードルドラッグデリバリーシステム市場2029年-最も新しい機会を提供する国
• マイクロニードルドラッグデリバリーシステム市場2029年-最も新しい機会を提供するセグメント
• マイクロニードルドラッグデリバリーシステム市場2029年-成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Microneedle Drug Delivery Systems are sophisticated medical devices that utilize arrays of micron-sized needles to deliver drugs, vaccines, and other therapeutic agents through the skin with minimal invasiveness. They penetrate the stratum corneum without reaching deeper nerve endings, thereby minimizing pain and discomfort.

The main types of technologies used in microneedle drug delivery systems include solid microneedle technology, hollow microneedle technology, dissolved microneedle technology, and others. In the solid microneedle method, peptides are dried onto the tips of a microneedle array, utilizing a coating of potent chemicals. These solid microneedles typically measure between 250 micrometers to 700 micrometers in length and are presented in patch form, allowing for storage at room temperature. Microneedle drug delivery systems find application in drug delivery, vaccine administration, and other therapeutic uses. They are employed in various settings such as diagnostic laboratories, life sciences, research laboratories, hospitals, ambulatory surgical centers, and other medical facilities.

The microneedles drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides microneedle drug delivery systems market statistics, including microneedle drug delivery systems industry global market size, regional shares, competitors with a microneedle drug delivery systems market share, detailed microneedles drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the microneedle drug delivery systems industry. This microneedle drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microneedle drug delivery systems market size has grown rapidly in recent years. It will grow from $5.01 billion in 2024 to $5.9 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to pain-free drug delivery, enhanced patient compliance, chronic disease management, cosmetic and aesthetic applications, vaccine administration.

The microneedle drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $11.44 billion in 2029 at a compound annual growth rate (CAGR) of 18.0%. The growth in the forecast period can be attributed to cosmetic and aesthetic applications, emergingTherapies, pediatric and geriatric use, global health initiatives, point-of-care testing. Major trends in the forecast period include smart microneedles, advancements in material science, advancements in wearable technology, biodegradable materials, continuous glucose monitoring.

The growing research efforts and demand for vaccination are anticipated to drive the growth of the microneedle drug delivery systems market. Researchers see microneedles as an alternative method for vaccine administration, allowing recipients to experience little to no pain. Initially developed for flu and measles vaccines, microneedle patches are now increasingly utilized for the delivery of COVID-19 vaccines as well. For example, in April 2024, the Office for National Statistics, a UK-based government agency, reported that the UK government's net expenditure on research and development (R&D), excluding contributions to the EU R&D budget, rose to $17.01 billion (£15.5 billion) in 2022, up from $15.37 billion (£14.0 billion) in 2021, reflecting a 10.5% increase. Including contributions to the EU R&D budget and knowledge transfer activities, total net expenditure on R&D reached $18.006 billion (£16.4 billion) in 2022, marking an 8.9% increase from $16.46 billion (£15.0 billion) in 2021. Thus, the rise in research and demand for the vaccination process is propelling the microneedle drug delivery systems market moving forward.

The rising prevalence of obesity is expected to drive the growth of the microneedle drug delivery systems market in the future. Obesity is a medical condition defined by an excess of body fat that can adversely affect an individual's health. Microneedle drug delivery systems are utilized for obesity management by providing a convenient and painless method for administering medications to patients. For example, in May 2024, the Office for Health Improvement and Disparities, a UK-based government agency, estimated that 64.0% of adults aged 18 and older in England were either overweight or living with obesity between 2022 and 2023. Of these individuals, 26.2% were classified as living with obesity. The prevalence of being overweight (including obesity) was higher in men (69.2%) than in women (58.6%). However, obesity rates among adults were comparable for both genders, with 26.4% of men and 26.2% of women living with obesity. Therefore, the increasing prevalence of obesity is driving the growth of the microneedle drug delivery systems market.

Major companies in the microneedle drug delivery systems market are concentrating on product innovation, such as radiofrequency microneedle systems, to deliver dependable services to their customers. A radiofrequency microneedle system is a minimally invasive technology that integrates microneedles with radiofrequency energy to improve drug delivery and stimulate collagen production in the skin for both therapeutic and cosmetic purposes. For example, in February 2023, Candela, a US-based medical aesthetic device manufacturer, introduced the Profound Matrix system. This multi-application system includes the Sublime, Sublative RF, and the cutting-edge Matrix Pro applicators. Both the Sublime and Sublative RF utilize bipolar radiofrequency (RF) technology to enhance the appearance of fine lines and wrinkles, while the Matrix Pro applicator is designed to regenerate and stimulate collagen production. It features a series of slender microneedles that deliver short-pulse RF energy to the skin, resulting in improved patient comfort, decreased downtime, and enhanced overall outcomes.

Major companies in the microneedle drug delivery systems market are forming partnerships to boost their profitability. For example, in January 2024, Cynosure, a US-based manufacturer of medical and aesthetic treatment systems, collaborated with LaserAway, a US-based provider of aesthetic dermatology, to expand the availability of the Potenza RF Microneedling technology to all LaserAway locations across the country. This partnership allows LaserAway to offer RF Microneedling to a wider patient demographic throughout the United States. Proponents emphasize that Potenza, a four-mode RF microneedling device, enhances customization options for clinicians and advances the capabilities of RF microneedling technology.

In November 2022, Kindeva Drug Delivery, a US-based drug delivery company, merged with Meridian Medical Technologies. The integration of Kindeva Drug Delivery and Meridian Medical Technologies will emphasize several key technologies, including parenteral drug delivery via autoinjectors, inhalation devices, transdermal delivery systems, and intradermal delivery techniques. Meridian Medical Technologies is a US-based manufacturer specializing in drug delivery systems.

Major companies operating in the microneedle drug delivery systems market include 3M Company, Zosano Pharma Corporation, Becton-Dickinson Technologies, Nanopass Technologies, Corium Inc., Valeritas Inc., Microdermics, TheraJect Inc., LTS Lohmann Therapie-Systeme AG, BioSerenTach (BT), Sorrento Therapeutics, Debiotech, Raphas Co. Ltd., QuadMedicine, Snvia Co. Ltd., NanoBiosciences LLC, AdminMed nanoBioSciences LLC, Nitto Denko Corporation, MyLife Technologies, Innoture Medical Technology Limited, Phillips-Medisize Corporation, Stemedica Cell Technologies Inc., Candela Corporation, Dermaroller GmbH, Micropoint Technologies, Vaxess Technologies, Micron Biomedical Inc., Kindeva Drug Delivery, Gurnet Point Capital, Moonlight Therapeutics Inc., Cutanos, Kimberly-Clark Corp., Clearside BioMedical Inc.

North America was the largest region in the microneedle drug delivery systems market in 2024. Europe was the second-largest region in the microneedle drug delivery systems market analysis. The regions covered in the microneedle drug delivery systems share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the microneedle drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The microneedle drug delivery systems market consists of sales of hydrogel microneedles and dissolvable microneedle. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microneedle Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microneedle drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microneedle drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microneedle drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: Hollow; Porous; Solid; Other Technologies
• 2) By Application: Drug Delivery; Vaccine Delivery; Other Applications
• 3) By End-User: Diagnostics Laboratories; Life Sciences; Research Laboratories; Hospitals; Ambulatory Surgical Centers; Other End-Users
• Subsegments:
• 1) By Hollow: Solid Hollow Microneedles; Coated Hollow Microneedles
• 2) By Porous: Porous Silicon Microneedles; Hydrogel-Based Porous Microneedles
• 3) By Solid: Solid Microneedles For Vaccination; Solid Microneedles For Drug Delivery
• 4) By Other Technologies: Dissolving Microneedles; Biodegradable Microneedles; Micro-Infusion Systems
• Companies Mentioned: 3M Company; Zosano Pharma Corporation; Becton-Dickinson Technologies; Nanopass Technologies; Corium Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Microneedle Drug Delivery Systems Market Characteristics

3. Microneedle Drug Delivery Systems Market Trends And Strategies

4. Microneedle Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Microneedle Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

• 5.1. Global Microneedle Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Microneedle Drug Delivery Systems Market Growth Rate Analysis
• 5.4. Global Microneedle Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Microneedle Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Microneedle Drug Delivery Systems Total Addressable Market (TAM)

6. Microneedle Drug Delivery Systems Market Segmentation

• 6.1. Global Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hollow
• Porous
• Solid
• Other Technologies
• 6.2. Global Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Delivery
• Vaccine Delivery
• Other Applications
• 6.3. Global Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics Laboratories
• Life Sciences
• Research Laboratories
• Hospitals
• Ambulatory Surgical Centers
• Other End-Users
• 6.4. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Hollow, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solid Hollow Microneedles
• Coated Hollow Microneedles
• 6.5. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Porous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Porous Silicon Microneedles
• Hydrogel-Based Porous Microneedles
• 6.6. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Solid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solid Microneedles For Vaccination
• Solid Microneedles For Drug Delivery
• 6.7. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dissolving Microneedles
• Biodegradable Microneedles
• Micro-Infusion Systems

7. Microneedle Drug Delivery Systems Market Regional And Country Analysis

• 7.1. Global Microneedle Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Microneedle Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Microneedle Drug Delivery Systems Market

• 8.1. Asia-Pacific Microneedle Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Microneedle Drug Delivery Systems Market

• 9.1. China Microneedle Drug Delivery Systems Market Overview
• 9.2. China Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Microneedle Drug Delivery Systems Market

• 10.1. India Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Microneedle Drug Delivery Systems Market

• 11.1. Japan Microneedle Drug Delivery Systems Market Overview
• 11.2. Japan Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Microneedle Drug Delivery Systems Market

• 12.1. Australia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Microneedle Drug Delivery Systems Market

• 13.1. Indonesia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Microneedle Drug Delivery Systems Market

• 14.1. South Korea Microneedle Drug Delivery Systems Market Overview
• 14.2. South Korea Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Microneedle Drug Delivery Systems Market

• 15.1. Western Europe Microneedle Drug Delivery Systems Market Overview
• 15.2. Western Europe Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Microneedle Drug Delivery Systems Market

• 16.1. UK Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Microneedle Drug Delivery Systems Market

• 17.1. Germany Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Microneedle Drug Delivery Systems Market

• 18.1. France Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Microneedle Drug Delivery Systems Market

• 19.1. Italy Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Microneedle Drug Delivery Systems Market

• 20.1. Spain Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Microneedle Drug Delivery Systems Market

• 21.1. Eastern Europe Microneedle Drug Delivery Systems Market Overview
• 21.2. Eastern Europe Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Microneedle Drug Delivery Systems Market

• 22.1. Russia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Microneedle Drug Delivery Systems Market

• 23.1. North America Microneedle Drug Delivery Systems Market Overview
• 23.2. North America Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Microneedle Drug Delivery Systems Market

• 24.1. USA Microneedle Drug Delivery Systems Market Overview
• 24.2. USA Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Microneedle Drug Delivery Systems Market

• 25.1. Canada Microneedle Drug Delivery Systems Market Overview
• 25.2. Canada Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Microneedle Drug Delivery Systems Market

• 26.1. South America Microneedle Drug Delivery Systems Market Overview
• 26.2. South America Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Microneedle Drug Delivery Systems Market

• 27.1. Brazil Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Microneedle Drug Delivery Systems Market

• 28.1. Middle East Microneedle Drug Delivery Systems Market Overview
• 28.2. Middle East Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Microneedle Drug Delivery Systems Market

• 29.1. Africa Microneedle Drug Delivery Systems Market Overview
• 29.2. Africa Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Microneedle Drug Delivery Systems Market Competitive Landscape And Company Profiles

• 30.1. Microneedle Drug Delivery Systems Market Competitive Landscape
• 30.2. Microneedle Drug Delivery Systems Market Company Profiles
  • 30.2.1. 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Zosano Pharma Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Becton-Dickinson Technologies Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Nanopass Technologies Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Corium Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Microneedle Drug Delivery Systems Market Other Major And Innovative Companies

• 31.1. Valeritas Inc.
• 31.2. Microdermics
• 31.3. TheraJect Inc.
• 31.4. LTS Lohmann Therapie-Systeme AG
• 31.5. BioSerenTach (BT)
• 31.6. Sorrento Therapeutics
• 31.7. Debiotech
• 31.8. Raphas Co. Ltd.
• 31.9. QuadMedicine
• 31.10. Snvia Co. Ltd.
• 31.11. NanoBiosciences LLC
• 31.12. AdminMed nanoBioSciences LLC
• 31.13. Nitto Denko Corporation
• 31.14. MyLife Technologies
• 31.15. Innoture Medical Technology Limited

32. Global Microneedle Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Microneedle Drug Delivery Systems Market

34. Recent Developments In The Microneedle Drug Delivery Systems Market

35. Microneedle Drug Delivery Systems Market High Potential Countries, Segments and Strategies

• 35.1 Microneedle Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Microneedle Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Microneedle Drug Delivery Systems Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer